Does Triamterene Enhance Hydrochlorothiazide's Hypotensive Effect?

Summary and Comment |
January 14, 2016

Does Triamterene Enhance Hydrochlorothiazide's Hypotensive Effect?

  1. Allan S. Brett, MD

In an observational study, combination therapy was associated with slightly lower blood pressure than was HCTZ monotherapy.

  1. Allan S. Brett, MD

To mitigate the hypokalemic effects of hydrochlorothiazide (HCTZ), the drug is available in combination with the potassium-sparing diuretic triamterene (combination products are Dyazide, Maxzide, and generics). However, whether triamterene also enhances HCTZ's hypotensive effect is unclear. Researchers addressed this question in an observational analysis of electronic records serving a healthcare network in metropolitan Indianapolis. About 3000 HCTZ recipients who also received triamterene were compared with about 14,000 HCTZ recipients who did not; propensity-score analysis was performed to adjust for background differences in the two groups.

When HCTZ was used without other blood pressure (BP)–lowering drugs, mean BP was significantly lower with HCTZ/triamterene than with HCTZ alone (by 4 mm Hg systolic and 1 mm Hg diastolic). When HCTZ was used with other drug classes (e.g., angiotensin-converting–enzyme inhibitors, calcium-channel blockers, β-blockers), addition of triamterene was associated with smaller — albeit still statistically significant — mean differences in systolic BP (2–3 mm Hg lower).

Comment

When HCTZ-treated patients develop hypokalemia, combining HCTZ with triamterene is a reasonable alternative to prescribing supplemental potassium. This analysis suggests that triamterene might also lower BP modestly when added to HCTZ. The study's limitation, of course, is its retrospective observational nature.

Editor Disclosures at Time of Publication

  • Disclosures for Allan S. Brett, MD at time of publication Nothing to disclose

Citation(s):

Reader Comments (2)

DALE TERRELL Physician, Geriatrics, UAMS-SC

For women, at least, it would seem more logical to add spironolactone to HCTZ with the expectation of better anti-hypertensive effect (and other benefits on remodeling, etc.) and perhaps using triamterene in men.1533

e gaertner,MD Physician, Internal Medicine

how and where does chlorthalidone fit into the picture of BP control

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.